Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis
Background This review aims to evaluate the safety and efficacy of apixaban vs. vitamin K antagonists (VKAs) in patients on dialysis.Methods All types of studies published on PubMed, Embase, CENTRAL, and Web of Science up to 10 September 2023 and comparing outcomes of apixaban vs. VKA in dialysis pa...
Saved in:
Main Authors: | Yifang Zhang, Jialiang Wang, Nannan Shen, Jie Jiang, Yanna Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2349114 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term mortality in patients with end-stage renal disease undergoing hemodialysis and peritoneal dialysis: a propensity score matching retrospective study
by: Pengjie Zhang, et al.
Published: (2024-12-01) -
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
Pharmacological and psychological treatment of depression and anxiety
among hemodialyzed patients –
a review
by: Aleksandra Ćwiek
Published: (2024-07-01) -
Geospatial analysis of end-stage renal disease among patients attending hemodialysis units in Alexandria, Egypt
by: Reham A. EL-Hofy, et al.
Published: (2023-12-01) -
Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
by: Jan‐Hendrik Schipper, et al.
Published: (2025-02-01)